CDC Director Issues Alert on Pfizer’s COVID Pill: Warns of “Covid Rebound” and Positive Viral PCR
Facts Matter
The CDC recently issued a warning regarding Pfizer’s COVID-19 pills—the ones that were approved last year and sold under the name Paxlovid.
People usually take those pills after they contract COVID-19 to lessen the symptoms and lower the chance of hospitalization.
However, a new advisory from the CDC warns Americans that taking Paxlovid can actually lead to a rebound in COVID-19 symptoms—which is a problem that, according to new documentation from the FDA, they were aware of even during the clinical trial phase.
Facts Matter
The CDC recently issued a warning regarding Pfizer’s COVID-19 pills—the ones that were approved last year and sold under the name Paxlovid.
People usually take those pills after they contract COVID-19 to lessen the symptoms and lower the chance of hospitalization.
However, a new advisory from the CDC warns Americans that taking Paxlovid can actually lead to a rebound in COVID-19 symptoms—which is a problem that, according to new documentation from the FDA, they were aware of even during the clinical trial phase.
